Roquefort Therapeutics PLC (ROQ)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1.20p
Buy
1.40p
0.00p (+0.00%)
Prices updated at 19 Dec 2025, 16:21 GMT
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Stephen Paul West
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
1
Head office
85 Great Portland Street
London
United Kingdom
W1W 7LT
Key personnel
Owner name | Salary |
|---|---|
Ms. Jean Duvall Non-Executive Director | - |
Dr. Simon Sinclair Non-Executive Director | - |
Dr. Darrin Matthew Disley Executive Director, Managing Director(intm) | - |
Mr. Stephen Paul West Executive Director, Chairman | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| No data | |
Director dealings
Date | Action |
|---|---|
| 21 Nov 2025 | Purchase |
| 04 Jul 2025 | Purchase |
| 27 Jun 2025 | Purchase |
| 04 Feb 2025 | Purchase |
| 04 Feb 2025 | Purchase |
Please note that past performance is not a reliable indicator of future returns.